78 related articles for article (PubMed ID: 3273574)
1. [Early postoperative hemodynamic changes after mitral valve substitution].
Lanzillo G; Cellini C; Intonti MA; Pragliola C; Baruffi E
Chir Patol Sper; 1987 Dec; 35(6):137-44. PubMed ID: 3273574
[No Abstract] [Full Text] [Related]
2. The early course of pulmonary artery hypertension in patients undergoing mitral valve replacement with cardioplegic arrest.
Foltz BD; Hessel EA; Ivey TD
J Thorac Cardiovasc Surg; 1984 Aug; 88(2):238-47. PubMed ID: 6748718
[TBL] [Abstract][Full Text] [Related]
3. [Course of pulmonary hypertension in patients operated for rheumatic mitral heart disease].
Privalova EV; Cherepenin LP; Ershov VI; Baloian GM; Buravikhina TA; Ermakov AI; Ivanov AS
Ter Arkh; 2000; 72(4):58-62. PubMed ID: 10833802
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.
Yurtseven N; Karaca P; Uysal G; Ozkul V; Cimen S; Tuygun AK; Yuksek A; Canik S
Ann Thorac Cardiovasc Surg; 2006 Oct; 12(5):319-23. PubMed ID: 17095973
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic findings following replacement of the mitral valve with the Beall valve prosthesis.
Ramsey HW; Williams JC; Vernon CR; Wheat MW; Daicoff GR; Bartley TD
J Thorac Cardiovasc Surg; 1971 Oct; 62(4):624-30. PubMed ID: 5315275
[No Abstract] [Full Text] [Related]
6. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary hypertension in the remote period after mitral valve prosthesis].
Grishkiavichius AP; Dranenkene AI; Nogene GA
Grudn Khir; 1987; (2):25-8. PubMed ID: 3583046
[No Abstract] [Full Text] [Related]
8. [Mitral cardiopathies with extreme pulmonary vascular resistances. A description of 48 cases (author's transl)].
Bourthoumieux A; Longhini C; Pernot PG; Voloch JP; Slama R; Bouvrain Y
Ann Cardiol Angeiol (Paris); 1976; 25(1):59-67. PubMed ID: 1259342
[No Abstract] [Full Text] [Related]
9. Systemic and pulmonary hemodynamic changes immediately following mitral valve replacement in man.
McIlduff JB; Daggett WM; Buckley MJ; Lappas DG
J Cardiovasc Surg (Torino); 1980; 21(3):261-6. PubMed ID: 7391117
[TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic evaluation of pulmonary hypertension secondary to mitral valve disease].
Ruíz Ros JA; Sogorb Garrí F; Palacios Motilla V; Cebolla Rosell R; Algarra Vidal FJ
Rev Esp Cardiol; 1975; 28(6):517-26. PubMed ID: 1215607
[No Abstract] [Full Text] [Related]
11. [Changes in serum enzyme levels in the early period after heart valve implantation under extracorporeal circulation].
Zacny E; Lityński P; Koziorowska B; Janczy R; Andres J; Dziatkowiak AJ
Kardiol Pol; 1988; 31(7):458-64. PubMed ID: 3236632
[No Abstract] [Full Text] [Related]
12. [Hemodynamic results of replacing the mitral valve with an aortic xenobioprosthesis].
Fursov BA; Barbarash LS; Bogomolova MP; Bykova VA; Popov VV
Vestn Khir Im I I Grek; 1986 Feb; 136(2):17-21. PubMed ID: 3705335
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment for mitral valve defects with preponderance of mitral stenosis and high pulmonary vascular resistance. Clinical and hemodynamic observations 6 months after valve replacement].
Zieliński T; Korewicki J; Sliwiński M; Rajecka A; Pogorzelska H; Leszek P; Sadowski A
Kardiol Pol; 1993 Dec; 39(12):426-32; discussion 432-7. PubMed ID: 8289429
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and paraclinical findings on status following prosthetic heart valve replacement with special reference to the behavior of pulmonary pressure].
Assmann I; Knappe J; Dittrich P; Kassel P
Z Gesamte Inn Med; 1987 Oct; 42(19):539-43. PubMed ID: 3424885
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in acquired valvular cardiac disease: evaluation by a scintillation camera technique.
Krishnamurthy GT; Srinivasan NV; Blahd WH
J Nucl Med; 1972 Aug; 13(8):604-11. PubMed ID: 5041635
[No Abstract] [Full Text] [Related]
17. [Hemodynamic effects of verapamil in pulmonary hypertension caused by heart valve disease].
Marozsán I; Szatmáry L; Kelemen S
Orv Hetil; 1989 Apr; 130(18):945-8. PubMed ID: 2726244
[TBL] [Abstract][Full Text] [Related]
18. [Enalapril treatment of residual pulmonary hypertension in patients operated rheumatic mitral valve defects].
Privalova EV; Ershov VI; Ermakov AI; Ivanov AS; Baloian GM; Kulagina TI; Aksiuk MA; Dobrovol'skaia TN
Klin Med (Mosk); 2000; 78(2):40-2. PubMed ID: 10723151
[TBL] [Abstract][Full Text] [Related]
19. A single-center experience of the Sorin Bicarbon heart valve prosthesis: long-term clinical, hematological and hemodynamic results.
Whitaker DC; James SE; Walesby RK
J Heart Valve Dis; 2004 Jan; 13(1):97-102. PubMed ID: 14765847
[TBL] [Abstract][Full Text] [Related]
20. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
